Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Regan S Fulton

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Histopathology|January 16, 2016
Markers of metastatic carcinoma of breast originAllen M Gown, Regan S Fulton, Patricia L Kandalaft
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2015
Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohortChristine Garcia, Jenna S Kubat, Regan S Fulton, et al.
American Journal of Clinical Pathology|February 26, 2011
Fixation time does not affect expression of HER2/neuJeffrey D Goldsmith, D Craig Allred, Mary Beth Beasley, et al.
Breast Cancer Research : BCR|May 26, 2009
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivorsMarilyn L Kwan, Lawrence H Kushi, Erin Weltzien, et al.
Archives of Pathology & Laboratory Medicine|March 21, 2014
Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality CenterPatrick L Fitzgibbons, Linda A Bradley, Lisa A Fatheree, et al.
Archives of Pathology & Laboratory Medicine|July 25, 2019
Predictive Markers Require Thorough Analytic ValidationMegan L Troxell, Regan S Fulton, Paul E Swanson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Histopathology|January 16, 2016
Markers of metastatic carcinoma of breast originAllen M Gown, Regan S Fulton, Patricia L Kandalaft
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 13, 2015
Clinical outcomes and prognostic markers in uterine leiomyosarcoma: a population-based cohortChristine Garcia, Jenna S Kubat, Regan S Fulton, et al.
American Journal of Clinical Pathology|February 26, 2011
Fixation time does not affect expression of HER2/neuJeffrey D Goldsmith, D Craig Allred, Mary Beth Beasley, et al.
Breast Cancer Research : BCR|May 26, 2009
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivorsMarilyn L Kwan, Lawrence H Kushi, Erin Weltzien, et al.
Archives of Pathology & Laboratory Medicine|March 21, 2014
Principles of analytic validation of immunohistochemical assays: Guideline from the College of American Pathologists Pathology and Laboratory Quality CenterPatrick L Fitzgibbons, Linda A Bradley, Lisa A Fatheree, et al.
Archives of Pathology & Laboratory Medicine|July 25, 2019
Predictive Markers Require Thorough Analytic ValidationMegan L Troxell, Regan S Fulton, Paul E Swanson, et al.
Pageof 1